| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.002 | 1 |